期刊文献+

EGF+61基因多态性与肝硬化的相关性研究 被引量:1

Relationship between polymorphism of epidermal growth factor 5' UTR variant G61A gene and cirrhosis in Chinese
下载PDF
导出
摘要 目的探讨表皮生长因子(epidermal growth factor,EGF)G61A位点(EGF+61)多态性与肝硬化发生、发展的关系。方法运用多聚酶链式反应-限制性片段长度多态性(PCR-RFLP)技术,检测中国人群中147例肝硬化患者和227例正常对照者中EGF+61位点的基因型,分析其基因型及等位基因的分布频率。结果EGF+61位点AA基因型及A等位基因在正常对照者中的分布频率均高于肝硬化患者(7.0%vs6.1%,30.4%vs27.2%),但其差异均无统计学意义(P>0.05)。EGF+61位点AA基因型及A等位基因在不同的Child-Pugh分级的肝硬化中的分布频率及规律不一,差异均无统计学意义(P>0.05)。结论在中国人群中,EGF+61位点的基因多态性与肝硬化的发生和发展无密切相关性。 Objective To explore the relationship between polymorphism of epidermal growth factor 5'UTR variant G61A gene(EGF+61) and the occurrence as well as progression of cirrhosis in Chinese.Methods EGF+61 polymorphism was analyzed among 147 cirrhosis patients and 227 healthy controls by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) to evaluate the distribution frequency of the genotype and allele.Results The distribution frequency of AA genotype and A allele frequency of EGF+61 polymorphism were both higher in healthy controls than those in cirrhosis patients(7.0% vs 6.1%,30.4% vs 27.2%),but there was no significant difference in the distribution(P0.05).The distribution frequency of AA genotype and A allele frequency of EGF+61 polymorphism were different in all kinds of Child-pugh grades of cirrhosis,and there was still no significant difference in the distribution(P0.05).Conclusion The polymorphism of EGF+61 shows no close relationship to the occurrence and progression of cirrhosis in Chinese.
出处 《胃肠病学和肝病学杂志》 CAS 2010年第1期28-30,共3页 Chinese Journal of Gastroenterology and Hepatology
基金 国家自然科学基金(No.30770994)
关键词 表皮生长因子 多态性 单核苷酸 肝硬化 Epidermal growth factor(EGF) Polymorphism Mononucleotide Cirrhosis
  • 相关文献

参考文献10

  • 1丁晓东,范建高.重视肝硬化并发症的预防和治疗[J].胃肠病学和肝病学杂志,2009,18(4):279-281. 被引量:16
  • 2Hamai Y, Mstsummura S, Matsusaki K, et al. A single nucleotide polymorphism in the 5 ' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer [ J ]. Pathobiology, 2005, 72 ( 3 ) : 133-136.
  • 3Lanuti M, Liu G, Goodwin JM, et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome [ J]. Clin Cancer Res, 2008, 14 (10) : 3216-3222.
  • 4Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma [ J]. Lancet, 2002, 359(9304) : 397-401.
  • 5McCarron SL, Bateman AC, Theaker JM, et al. EGF + 61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma [J]. Int J Cancer, 2003, 107(4) : 673-675.
  • 6Kang HG, Choi JE, Lee WK, et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer [ J ]. Respirology, 2007, 12(6) : 902-905.
  • 7Hanninen K, Katila H, Anttila S, et al. Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients [J]. Psychiatr Res, 2007, 41 (1-2) : 8-14.
  • 8林菊生.重视肝硬化遗传易感性的研究[J].中华医学杂志,2003,83(13):1113-1115. 被引量:5
  • 9Costa BM, Ferreira P, Costa S, et al. Association between functional EGF + 61 polymorphism and glioma risk [ J]. Clin Cancer Res, 2007, 13(9) : 2621-2626.
  • 10Kang S, Kim JW, Park NH, et al. Epidermal growth factor 61 A/G polymnrphism and uterine cervical cancer [ J]. Int J Gynecol Cancer, 2007, 17(2) : 492-496.

二级参考文献28

  • 1de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension [ J ]. J Hepatol, 2005, 43 (1): 167-176.
  • 2D' Amico G, Garcia TG, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies [J]. J Hepatol, 2006, 44 (1): 217-231.
  • 3Carbonell N, Pauwels A, Sarfaty L, et al. hnproved survival after variceal bleeding in patients with cirrhosis [ J ]. Hepatology, 2004, 40 ( 3 ) : 652-659.
  • 4Triantos CK, Burroughs AK. Prevention of the development of varices and first portal hypertensive bleeding episode [ J ]. Best Pract Res Clin Gastroenterol, 2007, 21 ( 1 ) : 31-42.
  • 5Thabut D, Bernard CB. Management of acute bleeding from portal hypertension [ J]. Best Pract Res Clin Gastroenterol, 2007, 21 ( 1 ) : 19- 29.
  • 6Heller J, Sauerbruch T. Prevention of recurrent haemorrhage [ J ]. Best Pract Res Clin Gastroenterol, 2007, 21 ( 1 ) : 43-53.
  • 7Cheung J, Wong W, Zandieh I, et al. Acute management and secondary prophylaxis of esophageal variceal bleeding: a western Canadian survey [ J ]. Can J Gastroenterol, 2006, 20 ( 8 ) : 531-534.
  • 8Garcia TG, Sanyal A J, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis [ J ]. Hepatology, 2007, 46 (3): 922-938.
  • 9Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis [J]. Gut, 2006, 55 (Suppl6): 1-12.
  • 10Gines P, Cardenas A. The management of ascites and hyponatremia in cirrhosis [ J]. Semin Liver Dis, 2008, 28 (1) : 43-58.

共引文献19

同被引文献13

  • 1Zhang YM,Cao C,Liang K.Genetic polymorphism of epider-mal growth factor 61A>G and cancer risk:a meta-analysis[J].Cancer Epidemiol,2010,34(2):150-156.
  • 2Shahbazi M,Pravica V,Nasreen N,et al.Association betweenfunctional polymor-phismin EGF gene and malignant melanoma[J].Lancet,2002,359(9304):397-401.
  • 3Jadad AR,Moore RA,Carroll D,et al.Assessing the quality ofReports of randomized clinical trials:is blinding necessary?[J].Control Clin Trials,1996,17(1):1-12.
  • 4Yoneda N,Sato Y,Kitao A.Epidermal growth factor inducescytokeratin 19expression accompanied by increased growth abili-ties in human hepatocellular carcinoma[J].Lab Invest,2011,91(2):262-272.
  • 5Tanabe KK,Lemoine A,Finkelstein DM,et al.Epidermal growthfactor gene functional polymorphism and the risk of hepatocellularcarcinoma in patients with cirrhosis[J].JAMA,2008,299(1):53-60.
  • 6Qi P,Wang H,Chen YM,et al.No association of EGF 5′UTRvariant A61Gand hepatocellular carcinoma in Chinese patientswith chronic hepatitis B virus infection[J].Pathology,2009,41(6):555-560.
  • 7Li Y,Xie Q,Lu F,et al.Association between epidermal growthfactor 61A/G polymorphism and hepatocellular carcinoma sus-ceptibility in Chinese patients[J].Liver Int,2010,30(1):112-118.
  • 8Chen K,Wei Y,Yang H,et al.Epidermal growth factor+61G/A polymorphism and the risk of hepatocellular carcinoma in aChinese population[J].Genet Test Mol Biomarkers,2011,15(4):251-255.
  • 9Abu Dayyeh BK,Yang M,Fuchs BC,et al.A functional poly-morphism in the epidermal growth factor gene is associated withrisk for hepatocellular carcinoma[J].Gastroenterology,2011,141(1):141-149.
  • 10Pinto GR,Yoshioka FK,Clara OA,et al.Association study ofan epidermal growth factor gene functional polymorphism withthe risk and prognosis of gliomas in Brazil[J].Int J Biol Mark-ers,2009,24(4):277-281.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部